Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CANB

Can B (CANB) Stock Price, News & Analysis

Can B logo

About Can B Stock (NASDAQ:CANB)

Advanced Chart

Key Stats

Today's Range
$0.06
$0.07
50-Day Range
$0.37
$8.24
52-Week Range
$0.27
$1.05
Volume
225,035 shs
Average Volume
189,959 shs
Market Capitalization
$5.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Can B Corp. engages in the development, production, and sale of products and delivery devices containing cannabidiol. Its product portfolio includes hemp extract oils and sprays, pain and skin care, softgels and capsules, superfoods, supplements, bath and spa, and pets. The company was founded by Rolv Eitrem Heggenhougen and Romuald Stone on October 11, 2005 and is headquartered in Hicksville, NY.

Receive CANB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Can B and its competitors with MarketBeat's FREE daily newsletter.

CANB Stock News Headlines

M.A.G.A. is Finished – This Could be even Better
You’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big change. Make America Wealthy Again (M.A.W.A).
See More Headlines

CANB Stock Analysis - Frequently Asked Questions

Can B (CANB) raised $10 million in an IPO on Tuesday, August 9th 2022. The company issued 2,000,000 shares at $5.05 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Can B investors own include Fulcrum Therapeutics (FULC), Actinium Pharmaceuticals (ATNM), Provention Bio (PRVB), VIVUS (VVUS), Chimerix (CMRX), OpGen (OPGN) and Processa Pharmaceuticals (PCSA).

Company Calendar

Today
4/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Current Symbol
NASDAQ:CANB
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-9,740,000.00
Net Margins
-1,238.33%
Pretax Margin
-1,351.68%

Debt

Sales & Book Value

Annual Sales
$2.16 million
Price / Cash Flow
N/A
Book Value
($0.28) per share
Price / Book
-0.20

Miscellaneous

Free Float
74,137,000
Market Cap
$4.69 million
Optionable
Not Optionable
Beta
1.46
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:CANB) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners